The Top 300 Drugs of 2021, Provided by the ClinCalc DrugStats Database. 2021.

Cohen J. Switching omeprazole in Sweden and the United States. Am J Ther. 2003;10(5):370–6.

Article  PubMed  Google Scholar 

Boardman HF, Heeley G. The role of the pharmacist in the selection and use of over-the-counter proton-pump inhibitors. Int J Clin Pharm. 2015;37(5):709–16. https://doi.org/10.1007/s11096-015-0150-z.

Article  PubMed  PubMed Central  Google Scholar 

Johnson DA, Katz PO, Armstrong D, Cohen H, Delaney BC, Howden CW, et al. The safety of appropriate use of over-the-counter proton pump inhibitors: an evidence-based review and Delphi consensus. Drugs. 2017;77(5):547–61. https://doi.org/10.1007/s40265-017-0712-6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shanika LGT, Reynolds A, Pattison S, Braund R. Proton pump inhibitor use: systematic review of global trends and practices. Eur J Clin Pharmacol. 2023;79(9):1159–72. https://doi.org/10.1007/s00228-023-03534-z.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lassalle M, Le Tri T, Bardou M, Biour M, Kirchgesner J, Rouby F, et al. Use of proton pump inhibitors in adults in France: a nationwide drug utilization study. Eur J Clin Pharmacol. 2020;76(3):449–57. https://doi.org/10.1007/s00228-019-02810-1.

Article  CAS  PubMed  Google Scholar 

Pottegard A, Broe A, Hallas J, de Muckadell OB, Lassen AT, Lodrup AB. Use of proton-pump inhibitors among adults: a Danish nationwide drug utilization study. Ther Adv Gastroenterol. 2016;9(5):671–8. https://doi.org/10.1177/1756283X16650156.

Article  CAS  Google Scholar 

Halfdanarson OO, Pottegard A, Bjornsson ES, Lund SH, Ogmundsdottir MH, Steingrimsson E, et al. Proton-pump inhibitors among adults: a nationwide drug-utilization study. Ther Adv Gastroenterol. 2018;11:1756284818777943. https://doi.org/10.1177/1756284818777943.

Article  CAS  Google Scholar 

Torres-Bondia F, de Batlle J, Galvan L, Buti M, Barbe F, Pinol-Ripoll G. Evolution of the consumption trend of proton pump inhibitors in the Lleida Health Region between 2002 and 2015. BMC Public Health. 2022;22(1):818. https://doi.org/10.1186/s12889-022-13217-6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tosetti C, Nanni I. Use of proton pump inhibitors in general practice. World J Gastrointestinal Pharmacol Ther. 2017;8(3):180–5. https://doi.org/10.4292/wjgpt.v8.i3.180.

Article  Google Scholar 

Haastrup PF, Jarbol DE, Thompson W, Hansen JM, Sondergaard J, Rasmussen S. When does proton pump inhibitor treatment become long term? A scoping review. BMJ Open Gastroenterol. 2021. https://doi.org/10.1136/bmjgast-2020-000563.

Article  PubMed  PubMed Central  Google Scholar 

Namikawa K, Bjornsson ES. Rebound acid hypersecretion after withdrawal of long-term proton pump inhibitor (PPI) treatment-are PPIs addictive? Int J Mol Sci. 2024. https://doi.org/10.3390/ijms25105459.

Article  PubMed  PubMed Central  Google Scholar 

Boghossian TA, Rashid FJ, Thompson W, Welch V, Moayyedi P, Rojas-Fernandez C, et al. Deprescribing versus continuation of chronic proton pump inhibitor use in adults. Cochrane Database Syst Rev. 2017;3:CD011969. https://doi.org/10.1002/14651858.CD011969.pub2.

Article  PubMed  Google Scholar 

Liu Y, Zhu X, Li R, Zhang J, Zhang F. Proton pump inhibitor utilisation and potentially inappropriate prescribing analysis: insights from a single-centred retrospective study. BMJ Open. 2020;10(11): e040473. https://doi.org/10.1136/bmjopen-2020-040473.

Article  PubMed  PubMed Central  Google Scholar 

Dutta AK, Jain A, Jearth V, Mahajan R, Panigrahi MK, Sharma V, et al. Guidelines on optimizing the use of proton pump inhibitors: PPI stewardship. Indian J Gastroenterol. 2023;42(5):601–28. https://doi.org/10.1007/s12664-023-01428-7.

Article  PubMed  Google Scholar 

Mares-Garcia E, Palazon-Bru A, Martinez-Martin A, Folgado-de la Rosa DM, Pereira-Exposito A, Gil-Guillen VF. Non-guideline-recommended prescribing of proton pump inhibitors in the general population. Curr Med Res Opin. 2017;33(10):1725–9. https://doi.org/10.1080/03007995.2017.1308921.

Article  CAS  PubMed  Google Scholar 

Farrell B, Pottie K, Thompson W, Boghossian T, Pizzola L, Rashid FJ, et al. Deprescribing proton pump inhibitors: evidence-based clinical practice guideline. Can Fam Physician Med Fam Can. 2017;63(5):354–64.

Google Scholar 

Arnoux A, Bailhache M, Tetard C, Rebouissoux L, Clouzeau H, Lamireau T, et al. Proton pump inhibitors are still overprescribed for hospitalized children. Arch Pediatr. 2022;29(4):258–62. https://doi.org/10.1016/j.arcped.2022.02.004.

Article  CAS  PubMed  Google Scholar 

Celik F, Aypak C, Ozdemir A, Gorpelioglu S. Inappropriate prescribing of proton pump inhibitors in outpatient clinics. Gastroenterol Nurs. 2021;44(2):84–91. https://doi.org/10.1097/SGA.0000000000000500.

Article  PubMed  Google Scholar 

Abrignani MG, Lombardo A, Braschi A, Renda N, Abrignani V. Proton pump inhibitors and gastroprotection in patients treated with antithrombotic drugs: a cardiologic point of view. World J Cardiol. 2023;15(8):375–94. https://doi.org/10.4330/wjc.v15.i8.375.

Article  PubMed  PubMed Central  Google Scholar 

Kanno T, Moayyedi P. Who needs gastroprotection in 2020? Curr Treat Opt Gastroenterol. 2020;18(4):557–73. https://doi.org/10.1007/s11938-020-00316-9.

Article  Google Scholar 

van der Zanden TM, Smeets NJL, de Hoop-Sommen M, Schwerzel MFT, Huang HJ, Barten LJC, et al. Off-label, but on-evidence? A review of the level of evidence for pediatric pharmacotherapy. Clin Pharmacol Ther. 2022;112(6):1243–53. https://doi.org/10.1002/cpt.2736.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tafuri G, Trotta F, Leufkens HG, Martini N, Sagliocca L, Traversa G. Off-label use of medicines in children: can available evidence avoid useless paediatric trials? The case of proton pump inhibitors for the treatment of gastroesophageal reflux disease. Eur J Clin Pharmacol. 2009;65(2):209–16. https://doi.org/10.1007/s00228-008-0560-0.

Article  PubMed  Google Scholar 

Tan J, Jeffries S, Carr R. A review of histamine-2 receptor antagonist and proton pump inhibitor therapy for gastroesophageal reflux disease in neonates and infants. Paediatr Drugs. 2023;25(5):557–76. https://doi.org/10.1007/s40272-023-00580-z.

Article  PubMed  Google Scholar 

Zoizner-Agar G, Rotsides JM, Shao Q, Rickert S, Ward R, Greifer M, et al. Proton pump inhibitor administration in neonates and infants. Lack of consensus—an ASPO survey. Int J Pediatr Otorhinolaryngol. 2020;137: 110200. https://doi.org/10.1016/j.ijporl.2020.110200.

Article  PubMed  Google Scholar 

Lassalle M, Zureik M, Dray-Spira R. Proton pump inhibitor use and risk of serious infections in young children. JAMA Pediatr. 2023;177(10):1028–38. https://doi.org/10.1001/jamapediatrics.2023.2900.

Article  PubMed  PubMed Central  Google Scholar 

Krishnan U, Mousa H, Dall’Oglio L, Homaira N, Rosen R, Faure C, et al. ESPGHAN-NASPGHAN Guidelines for the evaluation and treatment of gastrointestinal and nutritional complications in children with esophageal atresia-tracheoesophageal fistula. J Pediatr Gastroenterol Nutr. 2016;63(5):550–70. https://doi.org/10.1097/MPG.0000000000001401.

Article  PubMed  Google Scholar 

Brusselaers N, Pereira M, Alm J, Engstrand L, Engstrand LH. Effect of proton pump inhibitors in infants with esophageal atresia on the gut microbiome: a pilot cohort. Gut Pathog. 2022;14(1):47. https://doi.org/10.1186/s13099-022-00518-9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tang TC, Leach ST, Krishnan U. Proton pump inhibitors, antibiotics, and atopy increase the risk of eosinophilic esophagitis in children with esophageal atresia. J Pediatr Gastroenterol Nutr. 2024;78(6):1317–28. https://doi.org/10.1002/jpn3.12129.

Article  CAS  PubMed  Google Scholar 

Dimitrov G, Aumar M, Duhamel A, Wanneveich M, Gottrand F. Proton pump inhibitors in esophageal atresia: a systematic review and meta-analysis. J Pediatr Gastroenterol Nutr. 2024;78(3):457–70. https://doi.org/10.1002/jpn3.12115.

Article  CAS